Effect of a protease inhibitor on bacterial multiplication
Gastaldi, G.; Mattiello, A.
Pathologica 63(923): 223-231
1971
ISSN/ISBN: 0031-2983 PMID: 5005231 Document Number: 37787
Document emailed within 1 workday
Related Documents
Gaillard, M.C.; Reichberg, S.B.; Nogueira, C.M.; Kilroe-Smith, T.A. 1993: Differences in elastase-binding activity of alpha 1-protease inhibitor and alpha 2-macroglobulin for asthma patients and control subjects with various alpha 1-protease inhibitor phenotypes Clinical Chemistry 39(4): 675-679Hosaka, S.; Hirono, I. 1980: Effect of leupeptin, a protease inhibitor, on the development of spontaneous tumors in strain A mice Gan 71(6): 913-917
Traber, D.L.; Adams, T.; Sziebert, L.; Williams, P.; Traber, L.D. 1984: Failure of a protease inhibitor to affect the cardiopulmonary response to endotoxin when combined with a cyclooxygenase inhibitor Circulatory Shock 13(4): 319-323
Synovets, A.S.; Pustovoĭt, P.I.; Levitskiĭ, A.P. 1983: Effect of the protease inhibitor contrical on liver and serum proteolytic enzyme activity in experimental cholestasis Klinicheskaia Khirurgiia 9: 66-67
Hoffmann, F.; Funk, M.; Linde, R.; Notheis, G.; Petropoulou, T.; Eberle, J.; Gürtler, L.; Belohradsky, B.H.; Wintergerst, U. 2002: Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection European Journal of Medical Research 7(7): 330-334
Czernicki, Z. 1977: Effect of agents increasing the resistance of the vascular wall as well as of trasylol (a protease inhibitor) on experimental brain edema Neurologia i Neurochirurgia Polska 11(4): 457-460
Seto, S.; Akahoshi, M.; Kusano, S.; Kitamura, S.; Hashiba, K. 1989: Central effect of aprotinin, a serine protease inhibitor, on blood pressure in spontaneously hypertensive and Wistar-Kyoto rats Advances in Experimental Medicine and Biology 247b: 49-54
Sabo, J.P.; Lang, B.; Elgadi, M.; Huang, F. 2015: Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers Antimicrobial Agents and ChemoTherapy 59(1): 514-519
Ohkoshi, M.; Fujii, S. 1982: Effect of oral administration of protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of 3-methylcholanthrene-induced carcinoma in mice Gan 73(1): 108-110
Della Porta, P.; Soeltl, R.; Krell, H.W.; Collins, K.; O'Donoghue, M.; Schmitt, M.; Krüger, A. 1999: Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo Anticancer Research 19(5b): 3809-3816
Shmeleva, E.I.; Mertsalova, N.U.; Sukhinova, E.V.; Kirillova, G.A.; Remova, T.N.; Bazhanova, I.G.; Ozeretskovskaia, M.N.; Britsina, M.V.; Ermolova, E.V.; Zakharova, N.S. 1997: The expression of Bordetella pertussis protective antigens during bacterial multiplication on a medium with a fixed chemical composition Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 47-50
Besson, C.; Jubault, V.; Viard, J.P.; Pialoux, G. 1998: Ketoacidosis associated with protease inhibitor therapy Aids 12(11): 1399-1400
Piliero, P.J. 2004: Atazanavir: A novel once-daily protease inhibitor Drugs of Today 40(11): 901-912
Tomas, E.; Samuel, I.; Bârnaure, F.; Cajal, N. 1982: The effect of ceruloplasmin on the multiplication and on some biological and physico-chemical characteristics of influenza virus A/PR8/34 (H0N1) cultivated on chorioallantoic membrane fragments. Note 1. Kinetics of virus multiplication and of some biological characteristics in the presence and absence of ceruloplasmin Virologie 33(2): 139-146
Bierl, H. 2003: Atazanavir--first protease inhibitor for one dose administration Deutsche Medizinische Wochenschrift 128(39): 2039-2040
Cabot de Vega, E.; Fontecha Gómez, B.J.; Solé Arnau, R.; Pedrol Clotet, E. 1999: Peripheral lipodystrophy associated with protease inhibitor therapy Revista Clinica Espanola 199(8): 546-547
Juhász, S. 1983: Studies on the protease inhibitor of Klebsiella aerogenes Acta Veterinaria Hungarica 31(4): 121-123
Race, E. 2001: Cross-resistance within the protease inhibitor class Antiviral Therapy 6(Suppl 2): 29-36
Buch, H.J. 1970: Treatment of arthrosis with protease-inhibitor Contrykal Das Deutsche Gesundheitswesen 25(20): 947-950
Viciana, P.; Miralles-Martín, P.; Knobel, H.; Gatell, J.M. 1998: Prevention of opportunistic infections in the protease inhibitor era Enfermedades Infecciosas y Microbiologia Clinica 16 Suppl. 1: 1-10